LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als

Anima Biotech - mRNA Lightning Platform

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine

PharmaCompass – Grow Your Pharma Business Digitally

Applied Sciences August-1 2020 - Browse Articles

Anima Biotech - mRNA Lightning Platform

Unlocking The Power of mRNA Vaccines and Therapies

Sponsor Detail Template – Chinese American Biopharmaceutical Society

Ned Pagliarulo BioPharma Dive

Knowledge Library -, Growth Advisory